FDA
label_change
· 2011-06-23
FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA documents a supplemental application for the generic combination butalbital, acetaminophen, and caffeine, indicating changes to the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE)